OvaScience, VC Fund Settle Investor Class Action For $15M
By Ivan Moreno ( March 7, 2022, 5:30 PM EST) -- OvaScience and its venture capital backer Longwood Fund have agreed to pay $15 million to resolve an investor class action saying the Massachusetts fertility company's alleged misrepresentations about the success of a new treatment eventually led to shareholder losses....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.